Elevation of proinflammatory cytokines in the brain have potent effects on altering physiological, behavioral, and cognitive processes. The mechanism(s) by which brain cytokines are induced during a peripheral immune challenge remains unclear since microorganisms/cytokines do not cross the blood-brain barrier (BBB). Recent studies indicate that central b-adrenergic receptors (b-ADRs) may mediate brain interleukin-1beta (IL-1) production. This has direct implications for the production of brain cytokines during a peripheral immune response since peripheral pathogens and cytokines rapidly stimulate brainstem catecholamine neurons via peripheral nerves and circumventricular pathways. Studies here examine the role of central b-ADRs in regulating brain cytokine production following peripheral Escherichia coli (E. coli) challenge. Rats were centrally administered propranolol (b-ADR antagonist) or vehicle followed by peripheral E. coli or saline and sacrificed 6 h later for measurement of cytokines. Pre-treatment with propranolol completely blocked the induction of brain IL-1 following E. coli. Surprisingly, central propranolol also attenuated E. coli-induced peripheral cytokines. To examine whether the attenuated peripheral cytokine response following central propranolol administration was due leakage of propranolol into the general circulation and blockade of peripheral b-blockade, nadolol (b-ADR antagonist that does not cross the BBB) was administered peripherally prior to E. coli. Nadolol administration did not block central cytokine production following E. coli, but instead enhanced both peripheral and central proinflammatory cytokine production. Furthermore, central administration of isoproterenol (b-ADR agonist) results in a time-dependent increase in brain IL-1 production. These data demonstrate central b-ADRs may play a critical role to induce brain IL-1, while peripheral b-ADRs inhibit cytokine response to bacterial challenge.
Introduction
Inflammatory cytokines (i.e. IL-1b, TNF-a, and IL-6), particularly IL-1b, are potent stimulators of brain-mediated sickness responses, which includes fever, decrease in food/water intake, decrease in exploration and social interaction, cognitive impairment, and activation of the sympathetic nervous system and hypothalamic-pituitary-adrenal axis (Dantzer, 2001; Kelley et al., 2003) . During a peripheral immune challenge increased levels of inflammatory cytokines can be measured in the brain, likely contributing to the initiation of sickness responses (Laye et al., 2000) . During a peripheral immune challenge, toll-like receptors (TLRs) expressed on peripheral cells (e.g. immune and endothelial) detect pathogens and initiate peripheral cytokine production, however, microorganisms and cytokines are too large to passively cross the blood-brain barrier (BBB) and directly stimulate cytokine production in the brain. Studies presented here investigate the possibility of alternative signaling pathways involved in the induction of brain proinflammatory cytokines following a peripheral immune challenge.
One potential pathway that has been suggested to be involved in stimulating inflammatory cytokines in the brain is the vagusto-nucleus of the solitary tract (NTS) pathway. This neural pathway has been well documented to be involved in immune-to-brain communication. Stimulation of this pathway occurs when peripheral cytokine levels increase and bind to cytokine receptors expressed on vagal paraganglia (Goehler et al., 1997) . This results in activation of vagal afferent neurons that project to the brainstem (Ek et al., 1998; Kurosawa et al., 1997; Niijima, 1996) and synapse on catecholamine neurons located in the NTS (Gaykema et al., 2007; Sumal et al., 1983) . C-Fos mapping studies demonstrate that vagal afferents and neurons within the NTS rapidly become activated following peripheral immune stimuli (e.g. pathogens or cytokine administration) (Brady et al., 1994; Day and Akil, 1996; Elmquist et al., 1996; Ericsson et al., 1994 
